Janux Therapeutics | DEFA14A: Others
Apr 29 16:27 ET
Janux Therapeutics | DEF 14A: Definitive information statements
Apr 29 16:20 ET
Janux Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 8 16:53 ET
Janux Therapeutics | 8-K: Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Mar 8 16:16 ET
Janux Therapeutics | 8-K: Current report
Feb 29 17:14 ET
Janux Therapeutics | 8-K: Current report
Feb 28 17:31 ET
Janux Therapeutics | 8-K: Current report
Feb 27 17:27 ET
Janux Therapeutics | 8-K: Current report
Feb 26 22:23 ET
Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
Nov 7, 2023 16:07 ET
Janux Therapeutics | 8-K: Janux Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
Aug 8, 2023 16:17 ET
Janux Therapeutics | 8-K: Current report
Jul 18, 2023 16:16 ET
Janux Therapeutics | 8-K: Current report
Jul 17, 2023 08:06 ET
Janux Therapeutics | 8-K: Current report
Jun 23, 2023 16:36 ET
Janux Therapeutics | 8-K: Current report
Jun 20, 2023 17:17 ET
Janux Therapeutics | 8-K: Current report
May 9, 2023 17:19 ET
Janux Therapeutics | 8-K: Janux Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
May 9, 2023 16:08 ET
Janux Therapeutics | DEFA14A: Others
Apr 28, 2023 16:52 ET
Janux Therapeutics | DEF 14A: Definitive proxy statements
Apr 28, 2023 16:48 ET
Janux Therapeutics | 8-K: Current report
Mar 31, 2023 17:03 ET
Janux Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 10, 2023 16:47 ET
No Data
No Data